● Recruiting

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

Condition: HER2-positive Breast Cancer · Sponsor: Hoffmann-La Roche

PhasePhase 2/Phase 3

Planned participants650

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to assess the efficacy and safety of RO7771950 in combination with trastuzumab and capecitabine, compared to tucatinib in combination with trastuzumab and capecitabine.

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: WO46069 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. only) · global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (109)

Hospital Provincial del Centenario	Rosario, Argentina	Recruiting
Monash Health	Clayton, Victoria, Australia	Recruiting
Barwon Health	Geelong, Victoria, Australia	Recruiting
Peter MacCallum Cancer Centre	Melbourne, Victoria, Australia	Recruiting
Lkh Salzburg - Univ. Klinikum Salzburg	Salzburg, Austria	Recruiting
Cliniques Universitaires St-Luc	Brussels, Belgium	Recruiting
Jessa Zkh (Campus Virga Jesse)	Hasselt, Belgium	Recruiting
AZ Groeninge	Kortrijk, Belgium	Recruiting
UZ Leuven Gasthuisberg	Leuven, Belgium	Recruiting
AZ St Maarten Campus Leopoldstr	Mechelen, Belgium	Recruiting
Clinique Ste-Elisabeth	Namur, Belgium	Recruiting
ZAS Sint Augustinus Wilrijk	Wilrijk, Belgium	Recruiting

+ 97 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07413939